Private Equity
Ellodi is developing a treatment of the eosinophilic esophagitis.
4 min read · 22 September 2020
TPG Capital will retain the rights to Adare's Eosinophilic Esophagitis (EoE) product, which has been spun out into a separate entity.
5 min read · 22 September 2020
Today, the company has annual revenues in excess of €460 million ($540 million) and 850 employees.
3 min read · 22 September 2020
Odyssey previously weighed buying ProPharma through existing portfolio company TrialCard, three sources said.
3 min read · 22 September 2020
As part of the deal, founders Richard and Jan Conley will remain shareholders of the company, and Sean Conley will remain CEO.
2 min read · 21 September 2020
The deal is Auxo's seventh acquisition from its debut fund, Auxo Growth Holdings I, which closed in fall of 2018.
4 min read · 21 September 2020
If a deal is reached, existing investors Berkshire Partners and TPG Growth are expected to remain minority investors in the provider of outsourced pharma services.
2 min read · 21 September 2020
The Fertility Partners has acquired a minority interest in Sequence46, a genetic testing laboratory based in Los Angeles.
3 min read · 21 September 2020
The Thurston Group, a healthcare-focused PE firm based in Chicago, also invested in the deal.
4 min read · 21 September 2020
The investment was made through Carlyle Partners VII, an $18.5 billion fund that makes majority and strategic minority investments primarily in the U.S. in targeted industries, including healthcare.
4 min read · 21 September 2020
